Rare germline alterations of myeloperoxidase predispose to myeloid neoplasms

髓过氧化物酶的罕见种系改变易导致髓系肿瘤

阅读:6
作者:Sunisa Kongkiatkamon, Laila Terkawi, Yihong Guan, Vera Adema, Metis Hasipek, Tatiana Dombrovski, Milo Co, Wencke Walter, Hassan Awada, Yvonne Parker, Stephan Hutter, Simona Pagliuca, Carmelo Gurnari, Heesun J Rogers, Manja Meggendorfer, Daniel J Lindner, Torsten Haferlach, Valeria Visconte, Thomas L

Abstract

Myeloperoxidase (MPO) gene alterations with variable clinical penetrance have been found in hereditary MPO deficiency, but their leukemia association in patients and carriers has not been established. Germline MPO alterations were found to be significantly enriched in myeloid neoplasms: 28 pathogenic/likely pathogenic variants were identified in 100 patients. The most common alterations were c.2031-2 A > C, R569W, M519fs* and Y173C accounting for about half of the cases. While functional experiments showed that the marrow stem cell pool of Mpo-/- mice was not increased, using competitive repopulation demonstrated that Mpo-/- grafts gained growth advantage over MPO wild type cells. This finding also correlated with increased clonogenic potential after serial replating in the setting of H2O2-induced oxidative stress. Furthermore, we demonstrated that H2O2-induced DNA damage and activation of error-prone DNA repair may result in secondary genetic damage potentially predisposing to leukemia leukemic evolution. In conclusion, our study for the first time demonstrates that germline MPO variants may constitute risk alleles for MN evolution.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。